It has also been demonstrated that aberrant DNA methylation in the genetic polymorphisms of the P16, MGMT and hMLH1 genes and MTHFR C677T in ESCC is significantly associated and is most likely a promising biomarker for diagnosis and prognosis (Wang et al., 2008). The gene discussed is MTHFR; the disease is esophageal squamous cell carcinoma.